These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8193521)

  • 101. An approach to the explanation of cell membrane alteration in primary hypertension.
    Postnov YV
    Hypertension; 1990 Mar; 15(3):332-7. PubMed ID: 1689273
    [No Abstract]   [Full Text] [Related]  

  • 102. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).
    Dahlöf B; Lindholm LH; Hansson L; Scherstén B; Ekbom T; Wester PO
    Lancet; 1991 Nov; 338(8778):1281-5. PubMed ID: 1682683
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
    BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Hypertension and coronary heart disease risk factor management.
    Houston MC
    Clin Auton Res; 1993 Dec; 3(6):357-61. PubMed ID: 8193521
    [TBL] [Abstract][Full Text] [Related]  

  • 105. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension.
    Houston MC
    Am Heart J; 1989 Apr; 117(4):911-51. PubMed ID: 2648781
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The management of hypertension and associated risk factors for the prevention of long-term cardiac complications.
    Houston MC
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S2-13. PubMed ID: 7692147
    [TBL] [Abstract][Full Text] [Related]  

  • 107. New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach.
    Houston MC
    Am Heart J; 1992 May; 123(5):1337-67. PubMed ID: 1575152
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
    Houston MC
    Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Antihypertensive therapy: new strategies beyond blood pressure control.
    Stumpe KO
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S1-4. PubMed ID: 1283182
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [New therapeutic outlooks in the treatment of the hypertensive patient].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Antihypertensive therapy in diabetic patients.
    Weidmann P; Boehlen LM; de Courten M; Ferrari P
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M
    J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Risk-benefit aspects of antihypertensive drugs.
    Holzgreve H; Middeke M
    Drugs; 1992; 44 Suppl 1():67-73. PubMed ID: 1283587
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.